United States· US:74690-016_097353b6-41d7-cea1-e063-6294a90aea19
Dr. C. Tuna Resurface Essential Day Cream
A medicinal product containing homosalate; octinoxate; octocrylene; avobenzone, registered in United States by Farmasi US LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HOMOSALATE; OCTINOXATE; OCTOCRYLENE; AVOBENZONE
- Manufacturer
- Farmasi US LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1174690016011 JAR in 1 BOX (74690-016-01) / 50 mL in 1 JAR
- ndc1174690-016-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2c81d29-e098-4f25-84df-117f66fa0228 GET /v1/drugs/e2c81d29-e098-4f25-84df-117f66fa0228?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "70; 50; 50; 20",
"substance": "HOMOSALATE; OCTINOXATE; OCTOCRYLENE; AVOBENZONE",
"productndc": "74690-016",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL; mg/mL; mg/mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about homosalate; octinoxate; octocrylene; avobenzone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.